Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.70 |
| ▸ | LPL | P06858 | 12/20 | 0.70 |
| ▸ | P4HB | P07237 | 1/20 | 0.42 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30462985 | 1.00 | LIPG (0.70) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL19858597 | 0.90 | LIPG (0.85) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL22722776 | 0.90 | LIPG (0.85) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL21065677 | 0.89 | LIPG (0.73) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL28718456 | 0.89 | LIPG (0.73) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL30024835 | 0.88 | LIPG (0.53) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL18180909 | 0.88 | LIPG (0.53) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL22722773 | 0.87 | LIPG (0.55) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL30216211 | 0.86 | LIPG (0.67) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL17014607 | 0.86 | LIPG (0.55) | LIPGLPLP4HBPDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577212-B2 | Compound and an organic semiconducting layer, an organic electronic device and a display or lighting device comprising the same | NOVALED GMBH (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-3790875-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| EP-3790875-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| US-20240213508-A1 | FLUORINE-CONTAINING COMPOUND HAVING SULFONIC ACID GROUP AND POLYMER ELECTROLYTE FUEL CELL | NISSAN CHEMICAL CORPORATION (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240213508-A1 | FLUORINE-CONTAINING COMPOUND HAVING SULFONIC ACID GROUP AND POLYMER ELECTROLYTE FUEL CELL | NISSAN CHEMICAL CORPORATION (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-3567039-B1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023117255-A1 | ORGANIC LIGHT EMITTING DIODE, DISPLAY COMPRISING THE SAME, AND COMPOUND | NOVALED GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023110330-A1 | COMPOUNDS FOR USE IN SEMICONDUCTIONG MATERIALS SUITABLE FOR ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2023-06-22 | — | — | WO | disclosed |
| EP-4198026-A1 | COMPOUNDS FOR USE IN SEMICONDUCTIONG MATERIALS SUITABLE FOR ELECTRONIC DEVICES | Novaled GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-4199133-A1 | ORGANIC LIGHT EMITTING DIODE, DISPLAY DEVICE COMPRISING THE SAME, AND COMPOUND | Novaled GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| US-20200361916-A1 | Triazine Compounds substituted with Bulky Groups | SAMSUNG SDI CO. LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| EP-3502106-B1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2020-09-02 | — | — | EP | disclosed |
| EP-3502106-B1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2020-09-02 | — | — | EP | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019215179-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | NOVALED GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| EP-3567039-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2019-11-13 | — | — | EP | disclosed |
| EP-3567039-A1 | N-HETEROARYLENE COMPOUNDS WITH LOW LUMO ENERGIES | Novaled GmbH (DE) | 2019-11-13 | — | — | EP | disclosed |
| EP-3533793-A1 | ORGANIC ELECTRONIC DEVICE, DISPLAY AND LIGHTING DEVICES COMPRISING THE SAME | Novaled GmbH (DE) | 2019-09-04 | — | — | EP | disclosed |
| EP-3502106-A1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | Novaled GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |
| EP-3502106-A1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | Novaled GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200361916-A1 | Triazine Compounds substituted with Bulky Groups | POU5F1, POU2F1, IKZF2 | LIPG 4760/4885LPL 4750/4885P4HB 2369/4885 |
| US-12577212-B2 | Compound and an organic semiconducting layer, an organic electronic device and a display or lighting device comprising the same | NR2C2, NR3C2, SCO2 | LIPG 2839/4885LPL 1896/4885P4HB 4319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.